T
ABBV icon

TCWP’s AbbVie ABBV Stock Holding History

TCWP’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,936
Closed -$504K – 2
2024
Q2 		$504K Buy
2,936
+315
+12% +$52.2K 1.24% 28
2024
Q1 		$477K Buy
2,621
+3
+0.1% +$517 1.27% 28
2023
Q4 		$406K Sell
2,618
-15,477
-86% -$2.26M 1.15% 28
2023
Q3 		$2.7M Buy
18,095
+224
+1% +$32.9K 2.05% 13
2023
Q2 		$2.41M Sell
17,871
-122
-0.7% -$17.9K 0.51% 56
2023
Q1 		$2.87M Sell
17,993
-3,397
-16% -$519K 0.54% 58
2022
Q4 		$3.46M Sell
21,390
-1,272
-6% -$195K 0.7% 45
2022
Q3 		$3.04M Buy
22,662
+906
+4% +$130K 0.64% 46
2022
Q2 		$3.33M Sell
21,756
-103
-0.5% -$15.7K 0.71% 39
2022
Q1 		$3.54M Buy
21,859
+2,402
+12% +$349K 0.64% 37
2021
Q4 		$2.63M Buy
+19,457
New +$2.3M 0.52% 63

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

TCWP's ABBV Position: Q3 2024 in Review

TCWP sold out of AbbVie (ABBV) in Q3 2024, closing a stake of 2,936 shares — an estimated $504K sold.

TCWP first reported a position in ABBV in Q4 2021 and held it in 11 quarters. The position peaked at $3.54M in Q1 2022. 3,498 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.

  • TCWP reported no remaining AbbVie position as of Q3 2024 after selling out during the quarter.
  • TCWP sold 2,936 AbbVie shares in Q3 2024, an estimated $504K.
  • TCWP first reported a position in AbbVie in Q4 2021 and held it in 11 quarters.
  • TCWP's AbbVie position peaked at $3.54M in Q1 2022.
  • 3,498 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.

Based on TCWP's 13F filing for Q3 2024.